These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32665104)

  • 41. Summary of the EMA Joint Regulators/Industry QbD workshop (London, UK; 28-29 January 2014).
    Cook G; France G; Holte Ø; Lorenti G; Tainsh D
    PDA J Pharm Sci Technol; 2016; 70(2):163-76. PubMed ID: 26797977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmaceutical quality by design: product and process development, understanding, and control.
    Yu LX
    Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space.
    Eon-duval A; Valax P; Solacroup T; Broly H; Gleixner R; Strat CL; Sutter J
    J Pharm Sci; 2012 Oct; 101(10):3604-18. PubMed ID: 22821774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute Method.
    Liu Y; Fernandez J; Pu Z; Zhang H; Cao L; Aguilar I; Ritz D; Luo R; Read A; Laures A; Lan K; Ubiera A; Smith A; Patel P; Liu A
    J Pharm Sci; 2020 Nov; 109(11):3319-3329. PubMed ID: 32758544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
    Steinwandter V; Herwig C
    PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System.
    Rolke R; Ramnarine E; Vinther A; Sawant A
    PDA J Pharm Sci Technol; 2020; 74(2):286-288. PubMed ID: 32179712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation.
    Adam S; Suzzi D; Radeke C; Khinast JG
    Eur J Pharm Sci; 2011 Jan; 42(1-2):106-15. PubMed ID: 21056102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of critical quality attributes for monoclonal antibodies using quality by design principles.
    Alt N; Zhang TY; Motchnik P; Taticek R; Quarmby V; Schlothauer T; Beck H; Emrich T; Harris RJ
    Biologicals; 2016 Sep; 44(5):291-305. PubMed ID: 27461239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.
    Liu H; Rivnay B; Avery K; Myung JH; Kozak D; Landrau N; Nivorozhkin A; Ashraf M; Yoon S
    Int J Pharm; 2020 Jul; 585():119473. PubMed ID: 32473373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stage 2 Process Performance Qualification (PPQ): a Scientific Approach to Determine the Number of PPQ Batches.
    Pazhayattil A; Alsmeyer D; Chen S; Hye M; Ingram M; Sanghvi P
    AAPS PharmSciTech; 2016 Aug; 17(4):829-33. PubMed ID: 26349690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products.
    Troiano G; Nolan J; Parsons D; Van Geen Hoven C; Zale S
    AAPS J; 2016 Nov; 18(6):1354-1365. PubMed ID: 27631558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach.
    Eon-Duval A; Broly H; Gleixner R
    Biotechnol Prog; 2012; 28(3):608-22. PubMed ID: 22473974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality by design case study: an integrated multivariate approach to drug product and process development.
    Huang J; Kaul G; Cai C; Chatlapalli R; Hernandez-Abad P; Ghosh K; Nagi A
    Int J Pharm; 2009 Dec; 382(1-2):23-32. PubMed ID: 19664698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PCMO L01-Setting Specifications for Biological Investigational Medicinal Products.
    Krause SO
    PDA J Pharm Sci Technol; 2015; 69(5):569-89. PubMed ID: 26429107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why should the pharmaceutical industry claim for the implementation of second-order chemometric models-A critical review.
    Vignaduzzo SE; Maggio RM; Olivieri AC
    J Pharm Biomed Anal; 2020 Feb; 179():112965. PubMed ID: 31753531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ICH Q10 Pharmaceutical Quality System Guidance: Understanding Its Impact on Pharmaceutical Quality.
    VanDuyse SA; Fulford MJ; Bartlett MG
    AAPS J; 2021 Nov; 23(6):117. PubMed ID: 34773177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expectations for Phase-Appropriate Drug Substance and Drug Product Specifications for Early-Stage Protein Therapeutics.
    Kretsinger J; Frantz N; Hart SA; Kelley WP; Kitchen B; Novick S; Rellahan B; Stranges D; Stroop CJM; Yin P; Gastens MH
    J Pharm Sci; 2019 Apr; 108(4):1442-1452. PubMed ID: 30528942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.